PARIS (Reuters) - French drugmaker Sanofi said it won approval from the Japanese government for its Lyxumia drug for the treatment of Type 2 diabetes in combination with basal insulin. Lyxumia is part of a new class of diabetes treatments called GLP-1 analogues which prompt the body to release insulin when a diabetic's blood sugar level climbs too high. Lyxumia is now approved in Mexico, the European Union, Australia and Japan, Sanofi said in a statement on Friday. A new drug application for lixisenatide in the United States is currently being reviewed, it added. ... via Health News Headlines - Yahoo! News Read More Here..
Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/06/sanofi-wins-diabetes-drug-approval-in_28.html
No comments:
Post a Comment